Monophosphoryl Lipid A (Synthetic) (VAdv-Ly0012)

CAT Size Price Quantity
VAdv-Ly0012

Synthetic Monophosphoryl Lipid A, pure compound, a TLR4-based vaccine adjuvant.

Specifications
Type
Lipopolysaccharide
Formula
C96H184N3O22P
Product Form
White powder
Storage
Store at -20°C.
Adjuvant Information
Introduction
Synthetic Monophosphoryl Lipid A from E. coli (MPLA) is a pure compound produced by chemical synthesis that displays greatly reduced toxicity while maintaining most of the immunostimulatory activity of lipopolysaccharide. MPLA contains 6 fatty acyl groups, while MPLA purified from bacteria contains a mixture of 5, 6,and 7 acyl lipid A. MPLA is a potent stimulator of T cell and antibody responses. MPLA activates TLR4 but does not activate TLR2 reflecting its high purity. It has been used extensively in clinical trials as a component in prophylactic and therapeutic vaccines targeting infectious disease, cancer and allergies.
Related Product

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.


Online Inquiry

All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Project Description:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CONTACT US

USA

Tel:
Fax:
Email:
UK

Tel:
Email:
Germany

Tel:
Email:


Follow us on

Shopping Basket